FIGURE 7.

Lack of VAMP3 reverses the anti‐miR‐370‐3p–mediated effects on VSMC viability, migration and inflammation. VSMCs were treated with 100 µg/mL ox‐LDL, ox‐LDL +miR‐326‐3p inhibitors or ox‐LDL +miR‐326‐3p inhibitors +VAMP3 siRNA. A, B, The expression of VAMP3. C, Cell viability was detected by CCK‐8 assay. D, E, cell migration was evaluated by Transwell assay. Five visual fields were randomly selected to calculate the number of cells. F, G, The protein levels of IL‐6 and TNF‐α were determined using ELISA assay. Compared with the control group, *P < 0.05